226 related articles for article (PubMed ID: 7876105)
41. Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cells.
Ogihara T; Shin BC; Anai M; Katagiri H; Inukai K; Funaki M; Fukushima Y; Ishihara H; Takata K; Kikuchi M; Yazaki Y; Oka Y; Asano T
J Biol Chem; 1997 May; 272(19):12868-73. PubMed ID: 9139749
[TBL] [Abstract][Full Text] [Related]
42. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
43. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
44. Molecular cloning of an amphibian insulin receptor substrate 1-like cDNA and involvement of phosphatidylinositol 3-kinase in insulin-induced Xenopus oocyte maturation.
Liu XJ; Sorisky A; Zhu L; Pawson T
Mol Cell Biol; 1995 Jul; 15(7):3563-70. PubMed ID: 7791763
[TBL] [Abstract][Full Text] [Related]
45. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins.
Rameh LE; Chen CS; Cantley LC
Cell; 1995 Dec; 83(5):821-30. PubMed ID: 8521499
[TBL] [Abstract][Full Text] [Related]
46. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.
Nolte RT; Eck MJ; Schlessinger J; Shoelson SE; Harrison SC
Nat Struct Biol; 1996 Apr; 3(4):364-74. PubMed ID: 8599763
[TBL] [Abstract][Full Text] [Related]
47. Mutation of the two carboxyl-terminal tyrosines in the insulin receptor results in enhanced activation of mitogen-activated protein kinase.
Pang L; Milarski KL; Ohmichi M; Takata Y; Olefsky JM; Saltiel AR
J Biol Chem; 1994 Apr; 269(14):10604-8. PubMed ID: 8144649
[TBL] [Abstract][Full Text] [Related]
48. Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro.
Lehr S; Kotzka J; Herkner A; Sikmann A; Meyer HE; Krone W; Müller-Wieland D
Biochemistry; 2000 Sep; 39(35):10898-907. PubMed ID: 10978177
[TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
50. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.
Lamothe B; Bucchini D; Jami J; Joshi RL
FEBS Lett; 1995 Oct; 373(1):51-5. PubMed ID: 7589433
[TBL] [Abstract][Full Text] [Related]
51. Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation.
Myers MG; Grammer TC; Wang LM; Sun XJ; Pierce JH; Blenis J; White MF
J Biol Chem; 1994 Nov; 269(46):28783-9. PubMed ID: 7961833
[TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction.
Altschuler D; Yamamoto K; Lapetina EG
Mol Endocrinol; 1994 Sep; 8(9):1139-46. PubMed ID: 7838146
[TBL] [Abstract][Full Text] [Related]
53. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
[TBL] [Abstract][Full Text] [Related]
54. Changes in tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 (IRS-1) and association of p85 of phosphatidylinositol 3-kinase with IRS-1 after feeding in rat liver in vivo.
Ito Y; Ariga M; Takahashi S; Takenaka A; Hidaka T; Noguchi T
J Endocrinol; 1997 Aug; 154(2):267-73. PubMed ID: 9291837
[TBL] [Abstract][Full Text] [Related]
55. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
56. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action.
Deng Y; Bhattacharya S; Swamy OR; Tandon R; Wang Y; Janda R; Riedel H
J Biol Chem; 2003 Oct; 278(41):39311-22. PubMed ID: 12783867
[TBL] [Abstract][Full Text] [Related]
57. Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3'-kinase activity via modulation of phosphorylation of insulin receptor substrate-1.
Ugi S; Maegawa H; Kashiwagi A; Adachi M; Olefsky JM; Kikkawa R
J Biol Chem; 1996 May; 271(21):12595-602. PubMed ID: 8647870
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity.
Damen JE; Cutler RL; Jiao H; Yi T; Krystal G
J Biol Chem; 1995 Oct; 270(40):23402-8. PubMed ID: 7559499
[TBL] [Abstract][Full Text] [Related]
59. Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain.
Haefner B; Baxter R; Fincham VJ; Downes CP; Frame MC
J Biol Chem; 1995 Apr; 270(14):7937-43. PubMed ID: 7713890
[TBL] [Abstract][Full Text] [Related]
60. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
Tanaka S; Ito T; Wands JR
J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
